_version_ 1797292823541710848
author Vera Lúcia Teixeira de Freitas
Christina Terra Gallafrio Novaes
Ana Marli Christovam Sartori
Noemia Barbosa Carvalho
Sheila Cristina Vicente da Silva
Érika Shimoda Nakanishi
Fernando Salvador
Cleudson Nery de Castro
Rita Cristina Bezerra
Elizabeth Visone Nunes Westphalen
Caroline Medeji Ramos de Oliveira
Felipe Delatorre Busser
Yeh-Li Ho
Renata Buccheri
Carolina Bonilla
Maria Aparecida Shikanai-Yasuda
author_facet Vera Lúcia Teixeira de Freitas
Christina Terra Gallafrio Novaes
Ana Marli Christovam Sartori
Noemia Barbosa Carvalho
Sheila Cristina Vicente da Silva
Érika Shimoda Nakanishi
Fernando Salvador
Cleudson Nery de Castro
Rita Cristina Bezerra
Elizabeth Visone Nunes Westphalen
Caroline Medeji Ramos de Oliveira
Felipe Delatorre Busser
Yeh-Li Ho
Renata Buccheri
Carolina Bonilla
Maria Aparecida Shikanai-Yasuda
author_sort Vera Lúcia Teixeira de Freitas
collection DOAJ
first_indexed 2024-03-07T20:02:06Z
format Article
id doaj.art-61db229418a944a19e04f8504cfa7520
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-03-07T20:02:06Z
publishDate 2024-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-61db229418a944a19e04f8504cfa75202024-02-28T05:32:09ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352024-02-01182Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfectionVera Lúcia Teixeira de FreitasChristina Terra Gallafrio NovaesAna Marli Christovam SartoriNoemia Barbosa CarvalhoSheila Cristina Vicente da SilvaÉrika Shimoda NakanishiFernando SalvadorCleudson Nery de CastroRita Cristina BezerraElizabeth Visone Nunes WestphalenCaroline Medeji Ramos de OliveiraFelipe Delatorre BusserYeh-Li HoRenata BuccheriCarolina BonillaMaria Aparecida Shikanai-Yasudahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10896531/?tool=EBI
spellingShingle Vera Lúcia Teixeira de Freitas
Christina Terra Gallafrio Novaes
Ana Marli Christovam Sartori
Noemia Barbosa Carvalho
Sheila Cristina Vicente da Silva
Érika Shimoda Nakanishi
Fernando Salvador
Cleudson Nery de Castro
Rita Cristina Bezerra
Elizabeth Visone Nunes Westphalen
Caroline Medeji Ramos de Oliveira
Felipe Delatorre Busser
Yeh-Li Ho
Renata Buccheri
Carolina Bonilla
Maria Aparecida Shikanai-Yasuda
Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection
PLoS Neglected Tropical Diseases
title Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection
title_full Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection
title_fullStr Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection
title_full_unstemmed Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection
title_short Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection
title_sort quantitative pcr as a marker for preemptive therapy and its role in therapeutic control in trypanosoma cruzi hiv coinfection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10896531/?tool=EBI
work_keys_str_mv AT veraluciateixeiradefreitas quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT christinaterragallafrionovaes quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT anamarlichristovamsartori quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT noemiabarbosacarvalho quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT sheilacristinavicentedasilva quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT erikashimodanakanishi quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT fernandosalvador quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT cleudsonnerydecastro quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT ritacristinabezerra quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT elizabethvisonenuneswestphalen quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT carolinemedejiramosdeoliveira quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT felipedelatorrebusser quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT yehliho quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT renatabuccheri quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT carolinabonilla quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection
AT mariaaparecidashikanaiyasuda quantitativepcrasamarkerforpreemptivetherapyanditsroleintherapeuticcontrolintrypanosomacruzihivcoinfection